Used in biomedical research to measure levels of human glucocerebrosidase (GBA) enzyme in cell cultures, tissue extracts, and biological fluids such as cerebrospinal fluid. Enables researchers to study GBA activity and expression in neurodegenerative diseases, particularly Parkinson’s disease and Gaucher disease, where GBA mutations are a known risk factor. Supports investigation into enzyme replacement therapies, gene therapies, and pharmacological chaperones by providing a quantitative tool to assess treatment efficacy in preclinical and clinical studies. Also used in biomarker discovery and validation workflows to correlate GBA levels with disease progression or severity.